Antares Pharma Inc. (ATRS)

Antares Pharma Inc. (ATRS)
- P/E (TTM): 22.38X Cap: $955M
- View ATRS Profile
- View Questions on ATRS

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Antares Pharma Inc. (ATRS)
- P/E (TTM): 22.38X Cap: $955M
- View ATRS Profile
- View Questions on ATRS

Q: There is only 1 question on ATRS that came up on the symbol search but no answer to the question was shown. So apologies for duplication but was wondering... What is your opinion of ATRS as a 1-2 year hold in a growth portfolio?

Thanks

Read Answer Asked by Craig on November 20, 2017

Antares Pharma Inc. (ATRS)
- P/E (TTM): 22.38X Cap: $955M
- View ATRS Profile
- View Questions on ATRS

Q: Good morning from the West Coast. What is your opinion of ATRS as a long term hold in a growth portfolio?
Thanks
Rick

Read Answer Asked by Richard on October 10, 2017